Trial Profile
Phase I trial of AEOL 10150 for both therapeutic and prophylactic use in patients with cancer receiving radiation therapy.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 09 Sep 2016
Price :
$35
*
At a glance
- Drugs AEOL 10150 (Primary)
- Indications Radiation injuries
- Focus Adverse reactions
- 15 Aug 2016 According to Aeolus Pharmaceuticals media release, company is preparing for IND submissions to the FDA and initiating clinical study over the next two quarters.
- 15 Aug 2016 According to Aeolus Pharmaceuticals media release, planned initiation date changed from 1 Jul 2016 to 1 Jul 2017.
- 16 May 2016 According to Aeolus Pharmaceuticals media release, company is preparing for IND submissions to the FDA for later this year.